234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
CINCINNATI—An innovative approach to genome screening has yielded clues about rare mutations that may render people susceptible to brain bleeds, according to research led by a University of Cincinnati (UC) neurologist.
Joseph Broderick, MD, Albert Barnes Voorheis Chair of Neurology at the UC College of Medicine and research director of the UC Neuroscience Institute, is presenting the research Friday, Feb. 3, at the American Stroke Association’s International Stroke Conference 2012 in New Orleans.
For the first time, scientists applied a process called whole exome sequencing to seek gene mutations in families in which multiple relatives have intracranial aneurysms—weakened, ballooned-out areas in arteries of the brain that can rupture and cause a stroke, resulting in bleeding within the brain.
Learn more >>
* * *
The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, neuromuscular disorders, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).